Funded PrEP dispensings from July to December 2021
Thank you for your request dated 20 January 2022 under the Official Information Act 1982 (OIA) for information relating to PrEP. You requested:
Reimbursement claims data for July, Aug, Sept, Oct, Nov and Dec 2021
Please see the table below for the data requested. The number of funded PrEP dispensings reported is equal to the number of reimbursement claims received.
Table: Count of funded PrEP dispensings from July to December 2021
|
Month |
Dispensings |
|---|---|
| July | 1,945 |
| August | 1,753 |
| September | 1,603 |
| October | 1,630 |
| November | 1,776 |
| December | 1,929 |
Please note, a PrEP patient is defined as any patient dispensed only emtricitabine with tenofovir disoproxil and not any other antiretroviral. This is to exclude patients receiving emtricitabine with tenofovir disoproxil as part of an HIV treatment regimen (and thus not PrEP).
We trust that this information answers your queries. We are making our information more freely available, so we now publish selected OIA responses (excluding personal details) on our website. Please get in touch with us if you have any questions about this.